Shehwana, HumaKeskus, Ayse GokceOzdemir, E. SilaAcikgöz, Azer AylinBiyik-Sit, RumeysaCagnan, I.Gunes, DamlaJahja, ErmiraCingir-Koker, SahikaOlmezer, GizemSucularli, CerenKonu, Ozlen2022-02-162022-02-162021-04http://hdl.handle.net/11693/77429Cholinergic signals can be important modulators of cellular signaling in cancer. We recently have shown that knockdown of nicotinic acetylcholine receptor subunit alpha 5, CHRNA5, diminishes the proliferative potential of breast cancer cells. However, modulation of CHRNA5 expression in the context of estrogen signaling and its prognostic implications in breast cancer remained unexplored.EnglishBreast cancerCHRNA5Meta-analysisCo-expression networkEstrogen receptor targetsEstrogen treatmentPrognosisCHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancerArticle10.1007/s13402-020-00581-x1875-8606